Topical 2% Povidone-Iodine Gel in Verruca Vulgaris
Status:
Active, not recruiting
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-blind, placebo-controlled phase 2 study in
subjects 8 years of age and older who present with verruca vulgaris (common warts) and desire
treatment. Subjects may have up to a total of 6 common warts located on their trunk or
extremities that will be treated with study medication and followed throughout the study
protocol therapy. All warts will be treated two times per day (BID) for12 weeks.
Approximately 90 subjects will be enrolled in this study.